Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Charles Schwab Investment Management, now operating under the brand name Schwab Asset Management, is the asset management arm of The Charles Schwab Corporation. It is one of the largest investment managers in the United States, providing a wide array of products including exchange-traded funds (ETFs), mutual funds, and money market funds. The firm focuses on delivering low-cost, core investment strategies to individual investors, financial advisors, and institutional clients. While the company manages investment portfolios that may include significant holdings in the healthcare and biotechnology sectors, it is not a life sciences or healthcare company itself. Its primary business involves financial product engineering, portfolio management, and investment advisory services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Charles Schwab Investment Management.